Nuo Therapeutics, Inc. Asset Turnover Ratio (CMXI), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nuo Therapeutics, Inc.  (CMXI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Nuo Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nuo Therapeutics, Inc. asset turnover ratio, the ability of Nuo Therapeutics, Inc.'s assets to generate revenue in the second quarter 2026, increased sequentially to 0.16 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as CMXI's position remain challenging.

Within sector 18 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from to 3122.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CMXI Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Asset Change - - 1200 % 0.74 % -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.16 - - - -
CMXI's Total Ranking # 3122 # # # #
Seq. Asset Change 1945.67 % -2.67 % -99.61 % - -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 19
Healthcare Sector # 295
Overall Market # 3122

Asset Turnover Ratio Statistics
High Average Low
0.24 0.21 0.17
(Dec 31 2013)   (Sep 30 2014)




CMXI Company Profile • Back to CMXI Efficiency Comparisons • Compare CMXI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Marpai Inc  1.51 $ 16.635  Millions$ 11.010  Millions
Meiragtx Holdings Plc  1.48 $ 397.501  Millions$ 268.751  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Avita Medical Inc   1.38 $ 75.631  Millions$ 54.860  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Karyopharm Therapeutics Inc   1.31 $ 146.621  Millions$ 111.845  Millions
Aveanna Healthcare Holdings Inc   1.31 $ 2,602.820  Millions$ 1,987.815  Millions
Tactile Systems Technology Inc   1.29 $ 350.319  Millions$ 271.226  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Exagen Inc   1.27 $ 71.427  Millions$ 56.184  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Rockwell Medical inc   1.22 $ 69.827  Millions$ 57.145  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Nuwellis Inc   1.19 $ 9.013  Millions$ 7.547  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Universal Health Services Inc   1.16 $ 18,114.487  Millions$ 15,622.036  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Sunshine Biopharma Inc   1.15 $ 35.347  Millions$ 30.782  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.